[SCHEDULE 13G] PureTech Health plc American SEC Filing

Rhea-AI Filing Summary

Citigroup and several of its subsidiaries report a collective beneficial ownership of 13,220,374 ordinary shares of PureTech Health plc, representing 5.5% of the class. The filing names five Citigroup reporting persons and discloses that the position carries shared voting power and shared dispositive power; no sole voting or dispositive authority is reported.

The statement indicates the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The filing also describes the chain of ownership among the Citigroup entities that hold the position.

Positive

• Institutional ownership above 5% (13,220,374 shares) signals material investor interest in PureTech Health plc.
• Filing filed on Schedule 13G, indicating the holders assert a passive investment intent and certify the position is not to influence control.

Negative

• No sole voting or dispositive power reported; all authority is represented as shared across Citigroup entities.
• Holding is a minority stake (5.5%), which does not confer unilateral control or definitive governance influence.

Insights

Securities Analyst

TL;DR: Citigroup group reports a passive, material 5.5% stake (13.22M shares) with shared voting and dispositive power.

The Schedule 13G shows a meaningful institutional position above the 5% reporting threshold, reported on a form used for passive holdings. The filing discloses 13,220,374 shares (5.5%) and specifies shared voting and dispositive authority across Citigroup entities rather than any sole control. For investors, this documents substantive institutional interest without an expressed intent to influence corporate control.

Corporate Governance Expert

TL;DR: Shared voting/dispositive power across Citigroup subsidiaries; filing affirms ordinary-course, non-control holding.

The filing identifies the internal ownership chain among Citigroup entities and classifies the filers as a foreign financial institution. It explicitly states the position is held in the ordinary course of business and not to affect control. The absence of sole voting or dispositive power implies the stake is structured within group custody/activities rather than as an activist or controlling block.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Puretech Health Plc.

(Name of Issuer)

Ordinary Shares

(Title of Class of Securities)

G7297M101

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G7297M101

1

Names of Reporting Persons

Citigroup Global Markets Limited

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 13,220,374.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 13,220,374.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

13,220,374.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.5 %

12

Type of Reporting Person (See Instructions)

FI

SCHEDULE 13G

CUSIP No. G7297M101

1

Names of Reporting Persons

Citigroup Global Markets Holdings Bahamas Limited

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

BAHAMAS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 13,220,374.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 13,220,374.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

13,220,374.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.5 %

12

Type of Reporting Person (See Instructions)

FI

SCHEDULE 13G

CUSIP No. G7297M101

1

Names of Reporting Persons

Citigroup Financial Products Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 13,220,374.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 13,220,374.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

13,220,374.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.5 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP No. G7297M101

1

Names of Reporting Persons

Citigroup Global Markets Holdings Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 13,220,374.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 13,220,374.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

13,220,374.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.5 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP No. G7297M101

1

Names of Reporting Persons

Citigroup Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 13,220,374.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 13,220,374.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

13,220,374.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.5 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Puretech Health Plc.
(b)	Address of issuer's principal executive offices: 6 Tide Street, Suite 400, Boston MA 02210
Item 2.
(a)	Name of person filing: Citigroup Global Markets Limited ("CGML"), Citigroup Global Markets Holdings Bahamas Limited ("CGMHBL"), Citigroup Financial Products Inc. ("CFP"), Citigroup Global Markets Holdings Inc. ("CGM Holdings"), Citigroup Inc. ("Citigroup").
(b)	Address or principal business office or, if none, residence: CGML: 25 Canary Square, London GB E145LB. CGMHBL: Ocean Center, Montagu Foreshore, East Bay Street Nassau, New Providence Bahamas 19084. CFP, CGM Holdings and Citigroup: 388 Greenwich Street, New York, NY 10013.
(c)	Citizenship: CGML is chartered and headquartered in England. CGMHBL is chartered and headquartered in the Bahamas. CGM Holdings is a New York corporation. CFP and Citigroup are Delaware corporations.
(d)	Title of class of securities: Ordinary Shares
(e)	CUSIP No.: G7297M101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
	Foreign Financial Institution
Item 4.	Ownership
(a)	Amount beneficially owned: 13,220,374
(b)	Percent of class: 5.5 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 13,220,374
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 13,220,374
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. CGMHBL is the sole stockholder of CGML. CFP is the sole stockholder of CGMHBL. CGM Holdings is the sole stockholder of CFP. Citigroup is the sole stockholder of CGM Holdings.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Citigroup Global Markets Limited

Signature:	Simon Cumming
Name/Title:	Assistant Company Secretary
Date:	08/11/2025

Citigroup Global Markets Holdings Bahamas Limited

Signature:	David Graham
Name/Title:	UK Corporate Chain Controller
Date:	08/11/2025

Citigroup Financial Products Inc.

Signature:	Ronny Ostrow
Name/Title:	Assistant Secretary
Date:	08/11/2025

Citigroup Global Markets Holdings Inc.

Signature:	Ronny Ostrow
Name/Title:	Assistant Secretary
Date:	08/11/2025

Citigroup Inc.

Signature:	Ronny Ostrow
Name/Title:	Assistant Secretary
Date:	08/11/2025

FAQ

How many PureTech (PRTC) shares does Citigroup report owning?

Citigroup and its reporting entities disclose beneficial ownership of 13,220,374 shares of PureTech.

What percentage of PureTech (PRTC) does that represent?

The reported position represents 5.5% of PureTech Health plc's ordinary share class.

Does Citigroup have sole voting or dispositive power over these shares?

No; the filing states 0 sole voting power and 0 sole dispositive power, with 13,220,374 shares held with shared voting and dispositive power.

Is the holding reported as intended to influence control of PureTech (PRTC)?

No; the filers certify the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer.

Which Citigroup entities are named as reporting persons?

The filing names Citigroup Global Markets Limited, Citigroup Global Markets Holdings Bahamas Limited, Citigroup Financial Products Inc., Citigroup Global Markets Holdings Inc., and Citigroup Inc.